Loading...

Cantor's Dentice sees personalized medicine spurring M&A

78 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jul 18, 2012

The co-head of Cantor Fitzgerald's healthcare investment banking unit predicts that personalized medicine companies will become hot M&A targets for drugmakers and other life sciences companies.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...